Sort   by:  
 Page size 
UnknownGlobal, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.
Not available
S-EPMC12557468 | biostudies-literature
UnknownBurden of disease scenarios by state in the USA, 2022-50: a forecasting analysis for the Global Burden of Disease Study 2021.
Not available
S-EPMC11715278 | biostudies-literature
UnknownSame data, different analysts: variation in effect sizes due to analytical decisions in ecology and evolutionary biology.
Not available
S-EPMC11804095 | biostudies-literature
UnknownThiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC10245276 | biostudies-literature
UnknownSporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
Not available
S-EPMC4301065 | biostudies-literature
UnknownSubretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Not available
S-EPMC4549177 | biostudies-literature
UnknownAngiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Not available
S-EPMC4808340 | biostudies-literature
UnknownMacular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC3737287 | biostudies-literature
UnknownRanibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.
Not available
S-EPMC3389193 | biostudies-literature
UnknownComparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC4515372 | biostudies-literature
Sort   by:  
 Page size